Cardiff-based BBI Solutions, a leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market, has announced the launch of Porcine Liver Esterase (PLE), a new enzyme for urinalysis (BBI Solutions, 2016).

PLE is used in urinalysis controls as a partial substitute and potentially cost effective alternative for human leukocyte esterase. PLE acts on water soluble carboxyl esters containing short chain fatty acids. Assay control manufacturers can use PLE to detect the presence of white blood cells and other abnormalities associated with an infection of the urinary tract. Urinary tract infections are responsible for nearly 10 million doctor visits each year.

Janeske Oosthuizen, BBI’s Enzymes Product Manager, said “As an organisation it’s great to be able to bring another high quality product to the market. We always ensure our raw materials come from a secure source and through our validated manufacturing process we can guarantee a high quality product through batch to batch consistency, even in bulk quantities.”